Articles:

JJ Conn and HS Jacobs

The clinical management of hirsutism
Eur J Endocrinol 1997 136: 339-348.  

T Csikos, S Gallinat, and T Unger

Extrarenal aspects of angiotensin II function
Eur J Endocrinol 1997 136: 349-358. [Abstract]  

J Bertherat

An important role of IGF-I in intrauterine growth in humans
Eur J Endocrinol 1997 136: 366.  

U Plockinger, M Bader, W Hopfenmuller, W Saeger, and HJ Quabbe

Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology
Eur J Endocrinol 1997 136: 369-376. [Abstract]  

Z Laron, XL Wang, B Klinger, A Silbergeld, and DE Wilcken

Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)
Eur J Endocrinol 1997 136: 377-381. [Abstract]  

VL Green, MC White, LJ Hipkin, RV Jeffreys, PM Foy, and SL Atkin

Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas
Eur J Endocrinol 1997 136: 382-387. [Abstract]  

G van den Berg, SM Pincus, JD Veldhuis, M Frolich, and F Roelfsema

Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease
Eur J Endocrinol 1997 136: 394-400. [Abstract]  

A Juul, J Muller, and NE Skakkebaek

Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment
Eur J Endocrinol 1997 136: 401-405. [Abstract]  

PA Tomasi, G Fanciulli, M Zini, MA Demontis, A Dettori, and G Delitala

Pulsatile gonadotrophin secretion in hypothyroid women of reproductive age
Eur J Endocrinol 1997 136: 406-409. [Abstract]  

Y Sahin, D Ayata, and F Kelestimur

Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome
Eur J Endocrinol 1997 136: 410-415. [Abstract]  

MJ Bugalho, JP Frade, Santos, JR, E Limbert, and L Sobrinho

Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain
Eur J Endocrinol 1997 136: 423-426. [Abstract]  

T Umekawa, T Yoshida, N Sakane, M Saito, K Kumamoto, and M Kondo

Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat
Eur J Endocrinol 1997 136: 429-437. [Abstract]  

WN Kuhn-Velten

Improvement of cytochrome P450c17 catalytic processivity as a novel mechanism to attenuate hormonal consequences of enzyme decay in the testes after a gonadotropin surge
Eur J Endocrinol 1997 136: 438-443. [Abstract]  

Editorials:

P Chanson

Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits?
Eur J Endocrinol 1997 136: 359-361.  

E Danforth, Jr and JH Himms-Hagen

Obesity and diabetes and the beta-3 adrenergic receptor
Eur J Endocrinol 1997 136: 362-365.  

Clinical Studies:

M Kellner, I Diehl, K Knaudt, C Schule, H Jahn, and K Wiedemann

C-type natriuretic peptide exerts stimulatory effects on the corticotropin-releasing hormone-induced secretion of hormones in normal man
Eur J Endocrinol 1997 136: 388-393. [Abstract]  

GE Krassas, T Kaltsas, A Dumas, N Pontikides, and G Tolis

Lanreotide in the treatment of patients with thyroid eye disease
Eur J Endocrinol 1997 136: 416-422. [Abstract]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.